top of page
© Hairuhusiwi kukopi bila kibali cha ULYCLINIC

Mwandishi:

Mhariri:

Imeboreshwa:

ULY CLINIC

ULY CLINIC

1 Agosti 2026, 08:08:49

Image-empty-state.png

Male sexual dysfunction- Management

Male sexual dysfunction refers to difficulties affecting sexual performance and satisfaction, including problems with erection, ejaculation, orgasm, or sexual desire. The most common form is erectile dysfunction (ED), which is defined as the inability to achieve or maintain an erection sufficient for satisfactory sexual activity.


Erectile function requires coordinated interaction between vascular, neurological, hormonal, and psychological systems. Disruption of any of these pathways may result in sexual dysfunction.


Male sexual dysfunction may be caused by psychological factors, organic diseases, medications, or a combination of multiple factors. Because erectile dysfunction may be an early manifestation of systemic vascular disease, appropriate assessment is important to identify underlying medical conditions.


Epidemiology

Male sexual dysfunction is common and increases with advancing age. Erectile dysfunction affects a significant proportion of men worldwide and is strongly associated with chronic diseases such as diabetes mellitus, cardiovascular disease, and neurological disorders.

The prevalence increases with age due to increasing frequency of vascular disease, hormonal changes, medication use, and chronic illnesses.


Risk factors


Vascular causes

  • Atherosclerosis

  • Hypertension

  • Diabetes mellitus

  • Hyperlipidaemia

  • Cardiovascular disease

  • Smoking


Neurological causes

  • Spinal cord injury

  • Stroke

  • Multiple sclerosis

  • Peripheral neuropathy

  • Pelvic nerve injury


Endocrine causes

  • Hypogonadism

  • Thyroid disorders

  • Hyperprolactinaemia

  • Diabetes mellitus


Psychological factors

  • Depression

  • Anxiety

  • Stress

  • Relationship difficulties

  • Performance anxiety


Medication-related causes

Medications associated with sexual dysfunction include:

  • Antihypertensive drugs

  • Antidepressants

  • Antipsychotic medications

  • Hormonal therapies

  • Other drugs affecting neurological or vascular function


Lifestyle factors

  • Smoking

  • Excessive alcohol use

  • Obesity

  • Physical inactivity

  • Substance abuse


Pathophysiology

Normal erection requires:

  • Sexual stimulation.

  • Intact neurological pathways.

  • Adequate arterial blood flow.

  • Relaxation of penile smooth muscle.

  • Adequate hormonal function.


Sexual stimulation causes release of nitric oxide, resulting in increased cyclic guanosine monophosphate (cGMP) within penile tissue. This causes smooth muscle relaxation, increased blood flow into the corpora cavernosa, and penile erection.


Male sexual dysfunction occurs when there is impairment of:

  • Blood supply to the penis (vasculogenic dysfunction).

  • Nerve signalling (neurogenic dysfunction).

  • Hormonal regulation (endocrine dysfunction).

  • Psychological processes affecting sexual response.


Clinical presentation

Male sexual dysfunction may present with problems related to erection, ejaculation, orgasm, or sexual desire.


Symptoms


Erectile dysfunction

  • Difficulty achieving erection.

  • Difficulty maintaining erection.

  • Reduced penile rigidity.

  • Inability to achieve sufficient erection for vaginal penetration.


Ejaculatory dysfunction

  • Premature ejaculation.

  • Delayed ejaculation.

  • Failure to ejaculate.


Reduced sexual desire

  • Reduced interest in sexual activity.

  • Reduced sexual thoughts or motivation.


Associated symptoms

Symptoms related to underlying conditions may include:

  • Fatigue

  • Reduced muscle strength

  • Symptoms of diabetes

  • Symptoms of vascular disease

  • Neurological symptoms


Clinical signs

Physical examination may identify evidence of underlying disease:


General examination

  • Obesity

  • Features of cardiovascular disease

  • Signs of endocrine disorders


Genital examination

May reveal:

  • Penile abnormalities

  • Testicular abnormalities

  • Features suggesting hormonal deficiency


Neurological examination

May identify:

  • Peripheral neuropathy

  • Neurological deficits affecting sexual function


Diagnostic criteria

Diagnosis requires:

  • Persistent inability to achieve or maintain an erection sufficient for sexual activity.

  • Symptoms causing personal distress or relationship difficulties.

  • Assessment of possible underlying medical, psychological, or medication-related causes.


A detailed history is essential, including:

  • Onset and duration of symptoms.

  • Severity and pattern of dysfunction.

  • Presence of morning erections.

  • Sexual relationship factors.

  • Medication history.

  • Lifestyle factors.


Investigations

Investigations are guided by suspected underlying causes.


Blood investigations

May include:

  • Blood glucose or HbA1c for diabetes mellitus.

  • Lipid profile for cardiovascular risk assessment.

  • Testosterone level where hormonal deficiency is suspected.

  • Thyroid function tests where indicated.

  • Prolactin level when clinically appropriate.


Cardiovascular assessment

Because erectile dysfunction may indicate vascular disease, assessment of cardiovascular risk factors is important.


Additional investigations

Depending on clinical findings:

  • Neurological assessment.

  • Penile vascular studies in selected cases.

  • Specialist evaluation for complex cases.


Management

Management aims to:

  1. Identify and treat underlying causes.

  2. Modify reversible risk factors.

  3. Improve sexual function.

  4. Provide psychological and relationship support.

Treatment should be individualized according to the cause and severity of symptoms.


Non-pharmacological treatment


Education and counselling

Patients should receive counselling regarding:

  • Nature of the condition.

  • Relationship between lifestyle and sexual function.

  • Available treatment options.

  • Importance of managing underlying diseases.


Modification of contributing factors

Management includes:

  • Reviewing and removing medications associated with sexual dysfunction where possible.

  • Optimizing treatment of chronic diseases.

  • Addressing psychological factors.


Lifestyle modification

Patients should be advised to:

  • Stop smoking.

  • Reduce or stop excessive alcohol intake.

  • Maintain healthy body weight.

  • Engage in regular physical activity.

  • Improve cardiovascular health.

Lifestyle changes may improve erectile function, particularly when vascular risk factors are present.


Pharmacological treatment


Treatment of underlying conditions

Management should focus on correcting the underlying cause, including:

  • Control of diabetes mellitus.

  • Management of hypertension and cardiovascular disease.

  • Treatment of hormonal abnormalities.

  • Adjustment of contributing medications.


Other pharmacological therapy

Patients with persistent symptoms despite correction of contributing factors should be referred for specialist evaluation before initiation of specific erectile dysfunction medications.


Important note

The use of medications such as sildenafil may cause serious complications, particularly in patients with cardiovascular disease or those taking nitrate medications. These medicines should only be used after appropriate clinical assessment.


Management according to underlying cause


Vasculogenic erectile dysfunction

Management includes:

  • Lifestyle modification.

  • Cardiovascular risk reduction.

  • Treatment of vascular disease.


Neurogenic sexual dysfunction

Management includes:

  • Treatment of neurological disorders.

  • Rehabilitation and specialist care.


Endocrine-related sexual dysfunction

Management includes:

  • Identification and treatment of hormonal abnormalities.

  • Specialist evaluation where required.


Medication-related sexual dysfunction

Management includes:

  • Review of current medications.

  • Adjustment or substitution of causative drugs where clinically appropriate.


Psychological sexual dysfunction

Management includes:

  • Psychological counselling.

  • Psychosexual therapy.

  • Relationship counselling.


Referral

Refer patients for specialist evaluation if:

  • Symptoms persist despite correction of reversible causes.

  • Diagnosis is uncertain.

  • Suspected endocrine disorder.

  • Suspected neurological cause.

  • Significant psychological distress.

  • Complex erectile dysfunction requiring specialist treatment.


Referral may be made to:

  • Urologist

  • Endocrinologist

  • Psychiatrist or psychologist

  • Sexual health specialist

Complications

Untreated male sexual dysfunction may lead to:

  • Reduced quality of life.

  • Relationship difficulties.

  • Psychological distress.

  • Depression and anxiety.

  • Reduced self-esteem.

  • Missed diagnosis of underlying cardiovascular disease.


Prognosis

The prognosis depends on the underlying cause and response to treatment.

Sexual dysfunction caused by reversible factors such as medication effects, lifestyle factors, or psychological issues often improves with appropriate intervention. Dysfunction caused by chronic vascular, neurological, or systemic diseases may require long-term management.

Early identification and treatment of associated medical conditions improve outcomes.


Prevention

Prevention strategies include:

  • Maintaining a healthy lifestyle.

  • Regular physical activity.

  • Smoking cessation.

  • Limiting alcohol intake.

  • Maintaining healthy body weight.

  • Good control of diabetes and hypertension.

  • Early management of cardiovascular risk factors.

  • Avoiding unnecessary medications that affect sexual function.

  • Seeking early medical evaluation for persistent symptoms.

Imeandikwa:

25 Mei 2026, 17:33:53

Rejea za mada hii:

  1. Ministry of Health, Community Development, Gender, Elderly and Children. Standard Treatment Guidelines and National Essential Medicines List for Tanzania Mainland. 6th ed. Dodoma: Ministry of Health; 2021.

  2. European Association of Urology. EAU Guidelines on Sexual and Reproductive Health: Male Sexual Dysfunction. Arnhem: EAU Guidelines Office; 2025.

  3. Shamloul R, Ghanem H. Erectile dysfunction. Lancet. 2013;381(9861):153-165.

  4. McCabe MP, Sharlip ID, Lewis R, Atalla E, Balon R, Fisher AD, et al. Incidence and prevalence of sexual dysfunction in women and men: a consensus statement. J Sex Med. 2016;13(2):144-152.

  5. Burnett AL, Nehra A, Breau RH, Culkin DJ, Faraday MM, Hakim LS, et al. Erectile dysfunction: AUA guideline. J Urol. 2018;200(3):633-641.

  6. Jameson JL, Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J, editors. Harrison's Principles of Internal Medicine. 21st ed. New York: McGraw-Hill Education; 2022.

bottom of page